Gene · 23607
NIH grants1,872
NIH grants whose papers are about the gene, through NIH's grant-paper links.
781 to 800 of 1,872
Download this page as JSON| Grant | Title | CD2AP papers | Newest fiscal year |
|---|---|---|---|
| R01HL128300 | HDL Structure, Function and Dysfunction | 1 | 2019 |
| R01HL128439 | Genetic Control of Airway Epithelium Gene Expression in Childhood Asthmatics | 1 | 2019 |
| R01HL129132 | Genetic Studies of Blood Cell Traits in Multi-Ethnic Cohorts | 1 | 2019 |
| R01MH108467 | Statistical models for multi-modal brain imaging studies of HIV-associated cognitive decline | 1 | 2019 |
| R01NS063973 | Autophagy and Neurodegeneration | 1 | 2019 |
| R01NS094741 | Mechanisms controlling distinct modes of adult axon growth | 1 | 2019 |
| R03CA223615 | Regulation of KDM4A by Lysine Methylation | 1 | 2019 |
| R21ES028957 | Endocrine Disruptors, Ahr Signaling, and Placentation | 1 | 2019 |
| R25DA027995 | RESEARCH EDUCATION PROGRAM ON COMPUTATIONAL AND STATISTICAL TOOL DEVELOPMENT FOR ADDICTION GENETICS | 1 | 2019 |
| R56AG059756 | Genetics of Alzheimer's Disease in Mexico | 1 | 2019 |
| R56AG062633 | Elucidating the Role of Plasma Cholesterol in Alzheimer's Disease using Mendelian Randomization | 1 | 2019 |
| R56AG062762 | Aging and hyperglycemia alter molecular mechanisms and hippocampal oscillations consistent with Alzheimer's disease | 1 | 2019 |
| R56AG063908 | Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Orders | 1 | 2019 |
| RF1AG022018 | Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease | 1 | 2019 |
| RF1AG057457 | Building Novel Predictive Networks for high-throughput, in-silico Key Driver Prioritization to Enhance Drug Target Discovery in AMP-AD and M2OVE-AD | 1 | 2019 |
| RF1AG059717 | Translating SHIP1 Genetics to Generate a Novel Alzheimers Pharmacologic Agent | 1 | 2019 |
| RF1AG061351 | Functional genetic analyses of existing data resources to expand AD gene discovery | 1 | 2019 |
| RF1AG061846 | Protein conformer-resolved analysis of protein aggregates in Alzheimer's disease with mass spectrometry | 1 | 2019 |
| RF1AG063507 | Plasma Proteome and Risk of Alzheimer Dementia and Related Endophenotypes in the Framingham Study | 1 | 2019 |
| S10OD026880 | Big Omics Data Engine 2 Supercomputer | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/grants?page=40